Clinical Trials List
2023-09-15 - 2025-02-28
Phase II
Not yet recruiting4
Recruiting1
ICD-10C15.9
Malignant neoplasm of esophagus, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.9
Malignant neoplasm of esophagus, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Muh-Hwa Yang Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- 黃宣恩 Division of Radiology
- Chueh-Chuan Yen 醫學研究部
- Yi-Ping Hung Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chia-Chi Lin 無
- 郭弘揚 無
- JHE-CYUAN GUO 無
- TA-CHEN HUANG 無
- 莊建淮 無
- HUAI-CHENG HUANG 無
- Ta-Ching Chen Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
155 participants
